Tommy O'Connor Joins Interwell Health as New CEO
Interwell Health has recently welcomed Tommy O'Connor as its new Chief Executive Officer. Known for his extensive leadership experience in healthcare, O'Connor is tasked with guiding the organization’s mission to transform kidney care through innovative, value-based strategies designed to enhance patient outcomes while also reducing costs.
Transformative Leadership in Kidney Care
Having previously served as CEO for the Empire and Midwest Markets at UnitedHealthcare Medicare, O'Connor showcases a remarkable track record in establishing provider value-based partnerships. His leadership is expected to accelerate Interwell's growth as the leading provider of value-based kidney care solutions.
Significant Growth and Partnership Expansion
Under O'Connor’s guidance, Interwell Health aims to leverage its robust national network, which has expanded to over 2,300 nephrologist partners and manages care for more than 145,000 patients across the nation. This strategic expansion follows the successful merger of Cricket Health, Interwell Health, and Fresenius Health Partners, aimed at creating a comprehensive renal care solution.
Innovation at the Heart of Patient Care
O'Connor expressed enthusiasm about leading Interwell Health during this pivotal phase. He stated, "The passionate team at Interwell drives meaningful change for people living with kidney disease. We are well positioned to enhance innovation and improve patient outcomes while ensuring we establish industry standards.”
Commitment to Patient-Centered Care
Interwell Health is steadfastly dedicated to advancing patient-centered care models that address the intricate needs of individuals with chronic kidney disease (CKD). Through its innovative approach, the company combines advanced machine-learning algorithms and comprehensive care coordination to enhance service delivery and patient management.
Measuring Success in Value-Based Care
The leadership change comes at a time of robust momentum for Interwell Health, as it has gained recognition within the governmental framework of value-based kidney care models. The organization excels not only in clinical quality metrics but also in cost-effectiveness, making significant strides in transforming the kidney care landscape.
About Interwell Health
As a premier provider of value-based kidney care, Interwell Health is on a mission to reinvent healthcare for patients throughout their journey with chronic kidney disease. Interwell is committed to creating sustainable savings while delivering exceptional quality results at an unmatched scale. The company utilizes a dual approach—total patient care and provider enablement—to effectively manage CKD patients ranging from stage 3 to those facing kidney failure. Through partnerships with more than 2,300 nephrologists, Interwell’s interdisciplinary care team employs state-of-the-art algorithms to tailor treatments for patients across the United States and Puerto Rico.
Frequently Asked Questions
Who is the new CEO of Interwell Health?
Tommy O'Connor has been appointed as the new CEO of Interwell Health.
What experience does Tommy O'Connor bring?
O'Connor brings extensive healthcare leadership experience, including his role as CEO at UnitedHealthcare Medicare.
How many nephrologists are partnered with Interwell Health?
Interwell Health has partnerships with over 2,300 nephrologists.
What is Interwell Health's focus?
The organization's primary focus is to enhance value-based kidney care and improve patient outcomes.
What sets Interwell Health apart in the kidney care industry?
Interwell Health combines advanced machine learning with comprehensive care coordination, enabling it to drive innovation and quality in kidney care.
